PCI and ACS: Where do Vorapaxar vorapaxar and bivalirudin fit in? June 01, 2015 Overview Mostrar la transcripción Overview Naveen L. Pereira, M.D., assistant professor of medicine and pharmacology, and Gurpreet S. Sandhu, M.D., Ph.D., director of the Cardiac Catheterization Laboratory at Mayo Clinic's campus in Rochester, Minnesota, discuss adjunctive pharmacotherapy and coronary artery disease, with an emphasis on anticoagulation and antiplatelet drugs. VID-20433461 Profesionales médicos PCI and ACS: Where Do Vorapaxar and Bivalirudin Fit In?